Canada Union Proposes Measures to Ban "Evergreening" Drug Patents

Law360, New York (October 15, 2003, 12:00 AM EDT) -- Canada's second largest union is urging a parliamentary committee to recommend abolition of Canadian Patent Act regulations that "have been repeatedly abused by brand-name pharmaceutical companies," the 337,000-member National Union of Public and General Employees said Wednesday.

Union President James Clancy claimed the unfair practices of major drug companies is "preventing generic manufacturers from producing low cost alternatives after their already-excessive 20-year patent period ends."

He told the House of Commons Standing Committee on Health that the current legal framework has cost Canadians over Canadian $1...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.